C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2007
11/28/2007	EP1858911A2 Macromolecules comprising a thioether cross-link
11/28/2007	EP1858552A2 Composition comprising human igg2 antibody and a chelating agent
11/28/2007	EP1565559A4 Fluorescent proteins and chromoproteins from non-aequorea hydrozoa species and methods for using same
11/28/2007	EP1539238B1 Monoclonal antibodies and complementarity-determining regions binding to ebola glycoprotein
11/28/2007	EP1115863B1 Ucp4
11/28/2007	EP0977844B1 Mammal neuronal acid sensing cationic channel, cloning and applications thereof
11/28/2007	EP0959682B1 Therapeutic applications of laminin and laminin-derived protein fragments
11/28/2007	EP0910387B1 Apoptosis associated protein bbk
11/28/2007	CN101080421A Antibody and utilization of the same
11/28/2007	CN101080419A Compositions and methods of using angiopoietin-like 4 protein
11/28/2007	CN101077886A Recombination protein AMACR and application of the same in preparing prostate cancer diagnosis label
11/28/2007	CN100351375C In vitro peptide expression library
11/28/2007	CN100351267C Human urine anti-tumor (antibacterial) peptide, its preparation and use
11/28/2007	CN100351260C Polysaccharide vaccine for staphylococcal infections
11/28/2007	CN100350973C Drug composition for curing disease produced from IL-6
11/27/2007	US7301016 Comprises nucleotide sequences coding enzymatic polypeptide for diagnosing and treating cell proliferative disorders; animal models
11/27/2007	US7301007 PRO4340 polypeptides
11/27/2007	US7300929 Mediators of hedgehog signaling pathways, compositions and uses related thereto
11/27/2007	US7300916 Use of an erythropoietin antagonist for manufacture of a pharmaceutical preparation for preventing and/or treating hypertrophic scars, keloid or chronic arthritic diseases.
11/27/2007	US7300765 SC6 for diagnosis of cancers
11/27/2007	US7300753 immunoglobulin which binds phosphorylated ubiquitin fusion degradation protein 1 (UFD1) for use in diagnosis, prevention and treatment of cardiovascular and cell proliferative disorders
11/27/2007	US7300656 Treatment of inflammatory bowel disease with IFN-gamma inhibitors
11/27/2007	US7300655 Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof
11/27/2007	US7300653 Method of treating corneal transplant rejection
11/27/2007	US7300652 Contacting cell expressing kidney injury-molecule-1 (KIM-1) cell surface polypeptide with an effective amount of an isolated antibody or antigen-binding-fragment thereof that binds to the extracellular domain of the human KIM-1 polypeptide
11/27/2007	US7300651 Methods of delaying development of CEA-associated tumors using anti-idiotype antibody 3H1
11/22/2007	WO2007134327A2 Neutralizing antibodies to influenza viruses
11/22/2007	WO2007133290A2 Anti-ox40l antibodies and methods using same
11/22/2007	WO2007132917A1 Phage-displaying single-chain antibody capable of recognizing non-reduced mannose residue
11/22/2007	WO2007132789A1 Method for production of cleistogamous rice and method for selection of cleistogamous rice
11/22/2007	WO2007132512A1 Detection of inflammatory disease and composition for prevention or treatment of inflammatory disease
11/22/2007	WO2007131676A1 Method for the production of antibodies in immunodeficient animal injected with human fetal liver stem cells
11/22/2007	WO2007131363A1 Monoclonal antibodies to anthrax protective antigen
11/22/2007	WO2007131293A1 Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor vi
11/22/2007	WO2007131292A1 Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor xi
11/22/2007	WO2007131276A1 Enzymes for degrading herbicides
11/22/2007	WO2007039818A8 Antigen binding molecules having modified fc regions and altered binding to fc receptors
11/22/2007	WO2006092669A3 Methods of detecting a phenotype of a polymorphic protein
11/22/2007	WO2006076525A3 Combination cancer therapy with anti-psma antibodies
11/22/2007	WO2005044840A3 Modulation of anergy and methods for isolating anergy-modulating compounds
11/22/2007	WO2005012547A3 Multimeric oxidoreductases
11/22/2007	WO2003041483A3 Method to study and mechanisms of biofilm-related antibiotic resistance
11/22/2007	WO2003006672A3 Antimicrobial nucleic acid antibodies, and materials and methods for making and using same
11/22/2007	WO2000018212A8 Platelet-derived growth factor c, dna coding therefor, and uses thereof
11/22/2007	US20070271623 Plant Disease Resistance and Sar Regulator Protein
11/22/2007	US20070270575 Protein showing enhanced expression in cancer cells
11/22/2007	US20070270574 Subtilisin variants
11/22/2007	US20070270369 An antisense nucleic acid or an small interfering RNA (siRNA) that inhibits interaction of survivin with hepatitis B X-interacting protein (HBXIP);modified backbone comprises phosphorothioates; antiapoptosis; anticarcinogenic agents; antitumor agents; viricides; tissue-targeted therapy
11/22/2007	US20070270361 Sars Nucleic Acids, Proteins, Vaccines, and Uses Thereof
11/22/2007	US20070269881 Carotene Synthase Gene and Uses Therefor
11/22/2007	US20070269869 culturing under conditions effective to produce lipids lacking pigmentation from microorganisms Thraustochytriales, genetically modified to selectively delete or inactivate a carotene synthase gene comprising a nucleic acid sequence codes a protein havng phytoene dehydrogenase, lycopene cyclase activity
11/22/2007	US20070269867 Protein markers associated with bone marrow stem cell differentiation into early progenitor dendritic cells
11/22/2007	US20070269861 Soluble recombinant botulinum toxin proteins
11/22/2007	US20070269835 Reagent for determining laminin 5 antigen in biological sample and assay method
11/22/2007	US20070269464 Epitope synchronization in antigen presenting cells
11/22/2007	US20070269449 Fc Fusion Proteins
11/22/2007	US20070269446 Compositions and Methods for the Treatment of Tumor of Hematopoietic Origin
11/22/2007	US20070269445 Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV), proteins encoded by the polynucleic acids, vaccines based on the proteins and/or polynucleic acids, a method of protecting a pig from a PRRSV and a method of detecting a PRRSV
11/22/2007	US20070269444 Adjuvant Therapy with the Use of Anti-Glypican 3 Antibody
11/22/2007	US20070269443 Therapeutic Regimens for Baff Antagonists
11/22/2007	US20070269442 Chimeric monoclonal antibody recognizing iNOS
11/22/2007	US20070269441 Immunoregulation in cancer, chronic inflammatory and autoimmune diseases
11/22/2007	US20070269439 Use in diagnosis and treatment of cytokine disorders such as tumor metastasis, angiogenesis, cellular migration and ovulation, as well as neurogenesis
11/22/2007	US20070269438 Antibodies to the Human Prolactin Receptor
11/22/2007	US20070269437 Pro-Inflammatory and Anti-Inflammatory Antibodies Against the Heparin-Binding Protein (Hbp)
11/22/2007	US20070269436 Method of Antibody Production
11/22/2007	US20070269435 Modified fusion protein comprising an anti-EGFR immunoglobulin moiety and a cytokine polypeptide moiety linked together
11/22/2007	US20070269434 TAT-041 and methods of assessing and treating cancer
11/22/2007	US20070269433 Cell cycle progressional proteins
11/22/2007	US20070269429 Treatment with anti-erbb2 antibodies
11/22/2007	US20070269428 Method for the Treatment of Multiple Sclerosis by Inhibiting Il-17 Activity
11/22/2007	US20070269427 Therapeutical Use of Anti-Myelin Associated Glycoprotein (Mag) Antibodies
11/22/2007	US20070269426 Use of Soluble Gammadelta Cell Receptors for Regulating T Cell Function
11/22/2007	US20070269425 Anti-Idiotype Antibodies of the Human Monoclonal Antibody Sc-1, and Their Production and Use
11/22/2007	US20070269424 Moraxella bovis cytotoxin, cytotoxin gene, antibodies and vaccines for prevention and treatment of moraxella bovis infections
11/22/2007	US20070269423 kit comprises a nucleic acid, use for detection and treatment of human cancers by inhibiting the enzyme activities; biodrug as anticarcinogenic agents
11/22/2007	US20070269422 Serum albumin binding proteins with long half-lives
11/22/2007	US20070269372 monoclonal antibodies or fragment thereof which binds a cell surface glycoprotein antigen located on the surface of human multiple myeloma tumor cells; for therapeutic, screening, diagnostic and cell purification purposes
11/22/2007	US20070269371 Antibodies with altered effector functions
11/22/2007	CA2652570A1 Cd47 related compositions and methods for treating immunological diseases and disorders
11/22/2007	CA2652452A1 Neutralizing antibodies to influenza viruses
11/22/2007	CA2652103A1 Anthrax vaccine
11/22/2007	CA2651597A1 Detection of inflammatory disease and composition for prevention or treatment of inflammatory disease
11/22/2007	CA2651567A1 Binding polypeptides with optimized scaffolds
11/22/2007	CA2651428A1 Enzymes for degrading herbicides
11/22/2007	CA2651285A1 Methods and compositions for treatment of human immunodeficiency virus infection with conjugated antibodies or antibody fragments
11/22/2007	CA2651064A1 Novel agents and use thereof
11/22/2007	CA2650109A1 Method for the production of antibodies in immunodeficient animal injected with human fetal liver stem cells
11/22/2007	CA2633602A1 Anti-ox40l antibodies and methods using same
11/21/2007	EP1857554A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
11/21/2007	EP1857553A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
11/21/2007	EP1857551A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
11/21/2007	EP1857546A1 An animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
11/21/2007	EP1857466A2 Soluble interleukin-20 receptor
11/21/2007	EP1857465A1 Method of producing protein by using hamster igf-1
11/21/2007	EP1857464A2 Chlamydia antigens
11/21/2007	EP1857117A1 Agent for stimulating the production of a blood coagulation factor viii
11/21/2007	EP1857116A1 Antigen binding polypeptides against spike glycoprotein (S2) of bovine coronavirus
11/21/2007	EP1856539A2 Methods of predicting therpeutic response in atopic dermatitis to il-31 antagonists
11/21/2007	EP1856534A2 Peptides for detection of antibody to porcine reproductive respiratory syndrome virus

1 ... 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 ... 1494